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ABSTRACT Automation empowers self-sustainable adaptive processes and personalized services in many
industries. The implementation of the integrated healthcare paradigm built on Health 4.0 is expected to
transform any area inmedicine due to the lightning-speed advances in control, robotics, artificial intelligence,
sensors etc. The two objectives of this article, as addressed to different entities, are: i) to raise awareness
throughout the anesthesiologists about the usefulness of integrating automation and data exchange in their
clinical practice for providing increased attention to alarming situations, ii) to provide the actualized insights
of drug-delivery research in order to create an opening horizon towards precision medicine with significantly
improved human outcomes. This article presents a concise overview on the recent evolution of closed-loop
anesthesia delivery control systems by means of control strategies, depth of anesthesia monitors, patient
modelling, safety systems, and validation in clinical trials. For decades, anesthesia control has been in
the midst of transformative changes, going from simple controllers to integrative strategies of two or
more components, but not achieving yet the breakthrough of an integrated system. However, the scientific
advances that happen at high speed need a modern review to identify the current technological gaps, societal
implications, and implementation barriers. This article provides a good basis for control research in clinical
anesthesia to endorse new challenges for intelligent systems towards individualized patient care. At this
connection point of clinical and engineering frameworks through (semi-) automation, the following can be
granted: patient safety, economical efficiency, and clinicians’ efficacy.
INDEX TERMS Closed-loop control, drug-delivery control, anesthesia, (semi-)automated anesthesia deliv-
ery, cyber physical medical systems, decision support systems, adaptive control.
I. INTRODUCTION
Is anesthesia management prone to error? Can one believe
that such a standard procedure is applied optimally as a
familiar routine OR, on the contrary, with major risks due to
patient inter- and intra-variability? Either way, there is room
for improving the anesthesia optimization and decrease the
risks for the patients.
Driven by societal challenges, the fast progress of
advanced technology has been finding scalability to many
The associate editor coordinating the review of this manuscript and
approving it for publication was Nasim Ullah .
applied industries. The fourth industrial revolution’s effects
on the future of health and well-being are translated into
the emerging extension named Health 4.0 [1]. This pro-
cess is empowered by adaptable cyber physical systems
(CPSs), that integrate computation and physical entities
through communication infrastructure. Based on dynamical
context-awareness at different scales in the physical world,
CPSs allow semi-independent or independent execution of
advanced tasks [2]. So, the fusion of technologies across
physical, digital and biological areas resides at the core of
health sector performance and has a transformative impact
on drug delivery control systems. While close collaboration
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between engineers and clinicians are witnessing spectacular
growth, the essential role of drug control and modelling in
meeting one of the critical societal challenges (healthcare) is
envisaged across the research community [3].
CPSs have been on the rise in the medical field because of
their potential to project a transformative impact onmedicine.
In such a changing environment, the analysis of Big (health-
care) data seized in real-time achieves precision and indi-
vidualization towards the patient’s care, guiding specialists’
decisions based on context-awareness approach. The benefits
of the combination between a monitoring system, a control-
ling software, and a communication channel have been also
recognized in the operation room for surgical procedures or
for anesthesia delivery [4], [5], such that automated admin-
istered intravenous anesthesia had better results over manual
and target controlled infusion (TCI) techniques [6]. Effective
control of total intravenous anesthesia (TIVA) is one of the
most important issues in the field of surgery, because millions
of people worldwide undergo operations daily. Besides, inad-
equate intraoperative anesthesia or treatment of postopera-
tive pain can cause post-operatory complications. Unintended
intraoperative awareness with recall is a potential complica-
tion of under-dosing that continues to occur during TIVA [7].
An important role to maintain the positive balance is played
by computer-controlled infusion systems, whereas medicine
and engineering go hand-in-hand for better results [8]. The
decision actionsmust tackle: increased clinical workload, dif-
ferent anesthesia infusion practices to deal with large interpa-
tient variability (correlated with the doctor’s expertise level),
repeatedly use of constant drug infusion rate (slightly over-
dosing). A standardized high-quality anesthesia decision
support systems (DSS), reduction of post-operative effects,
individualized and adapted drug infusion, and robust mainte-
nance of target values are themain factorsmotivating automa-
tion in anesthesia administration.
While a hot topic, autonomous systems in anesthesia
have been deployed with considerable success in research,
as reviewed by Zaouter et al. [9], but limited in its imple-
mentation in hospitals in integrated medical cyber physical
systems (MCPSs). Over the past decades, research groups
have focused on multiple control strategies, patients states
monitors, adaptive optimization algorithms, drugs interac-
tions, modelling approaches, and more other components of
the complex process towards anesthesia control. The new
technology and methodologies brought by control systems
could change the way people receive anesthesia. It would
enable personalized services that are more responsive to
patient’s state, offering optimized drug doses and preventive
surgical approaches that ultimately create a more sustainable
patient peri- and post-anesthesia care.
The main contribution of this survey is the presentation of
the most recent closed-loop anesthesia systems in the actual
technological, societal, and economical context. The com-
plex paradigm of anesthesia regulation is described from the
viewpoint of control optimization, modelling, and feedback.
Moreover, this article discusses the social and economic value
creation through transfer of the innovative knowledge and
technology in anesthesia automation. The objectives of the
paper are addressed to both anesthesiologists and researchers.
In order to raise awareness between anesthesiologists, it is
motivated the potential of control integration in their clin-
ical practice as decision support systems, and not as their
replacement. On the other hand, a broad overview of the
actual trends on closed-loop anesthesia control is presented.
However, adoption of automated systems is not any more
a challenge in many domains, but healthcare and mostly in
anesthesia still miss control integration in the patient care.
The structure of the paper is further presented. Next section
introduces the parallelism between everyday clinical prac-
tice in open-loop versus closed-loop delivery of anesthetics.
Based on this comparison, the third section presents the
theoretical aspects needed to be met in anesthesia control
systems, by defining the particular specifications from the
control viewpoint. The overview of control strategies are
referred with recent publications in the fourth section, while
the opportune research perspectives driving innovations are
addressed in the final section.
II. ANESTHESIA: OPEN- VS CLOSED-LOOP
General anesthesia requires adequate balance between hyp-
nosis, analgesia, and neuromuscular blockade (NMB) [10],
while maintaining the other patient’s parameters in the safe
range. Technological monitoring assures detection and alarm
of complications, but clinical observation is essential based
on anesthetist’s skills and experience [11]. Appropriate mon-
itoring devices recommended in anesthetic standards are
summarized in Fig. 1 for depth of anesthesia (e.g., processed
electroencephalography, newly researched pain moni-
tors, peripheral neuromuscular transmission monitor), for
hemodynamics (pulse oximeter, electrocardiography, blood
pressure), for respiratory dynamics (oxygen supply, pulse
oximeter, auscultation, clinical observation), and for temper-
ature [10]. In this manner, the monitors supplement clini-
cal observation in order to achieve optimal drug doses for
anesthesia-hemodynamics-respiratory management. Fig. 1
endorses the integration of a cyber-physical-human sys-
tem (CPHS) in the clinical practice. Through its objective,
the context-aware control system can guide optimal infusion
rate and can release the anesthesiologist from its repeti-
tive tasks, such as continuous assessment of patient state
or implementation of well-defined international standards.
Moreover, the pandemic outbreak COVID-19 adds specific
risks paired with infected patients that need to be tack-
led (e.g. acute cardiac injury and arrhythmia) [12]. While
computer-based drug delivery can handle routine situations
for anesthesia and hemodynamics maintenance, the medical
specialists can focus on high rated tasks. Consequently,
a sedation-hemodynamic regulation during general anesthe-
sia can achieve its potential both in operating rooms and
intensive care units (ICU).
Delivery of anesthesia involves a repeated cycle of assess-
ing the patient’s state and using this data to adjust medication.
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FIGURE 1. Clinical care paradigm for patient’s state monitoring during general anesthesia and the potential of a hybrid CPHS with medical
human in the loop.
Nowadays, computer-controlled drug delivery is done by
open-loop target-controlled infusion (TCI) systems, the first
step toward automation of drug delivery. TCIs maintain a
constant infusion rate of the anesthetic, modeled using phar-
macokinetics principles for the target effect-site or plasma
concentrations dictated by the practitioner [13]. However,
the anesthesiologist is implied in the control loop by selecting
the initial target doses or concentrations and adjusting them
accordingly to the peri-operative evaluation of the patient’s
state. The effect of the drugs on each patient is assumed by
the clinicians based on monitoring devices, clinical expertise,
and previous experience. While this strategy is manually
closed by the anesthesiologist, closed-loop control systems
use direct measurements from depth of anesthesia monitors in
order to automatically adapt the infusion rates. The measured
response of the patient is used as feedback for the controller.
Then, the anesthesiologist receives other high-level roles,
such as manually monitoring of specific physiological signals
or changing the infusion doses in emergency cases.
There is no need in clinical settings to divide anes-
thesia delivery systems into two non-collaborative, sep-
arated groups (i.e. open- and closed- loop). Even if
most of the anesthesia control research revolves around
self-adaptive and human-independent closed-loop systems,
the human-machine collaboration is expected to bring added
value for the maintenance of the set anesthesia depth. The
solution can be the (semi-automated) hybrid systems, that
allow the interaction of the anesthesiologist with the con-
troller, which reacts on his actions (e.g., additive boluses),
thus avoiding several complications (e.g., anesthesia aware-
ness) [14]. Moreover, these systems provide support to
anesthesiologists in clinical decision making process through
the presentation of the decision inference. The latest was
reliably made by processing the available contextual data and
implying guidelines compliance.
Decision support systems (DDSs) have been developed for
accurate detection and alert of peri-operative issues, using
algorithms based on expert clinical knowledge or artificial
intelligence patterns [15]. Characterized by context aware-
ness, DSSs sense context information, evaluate the mod-
eled processed data with different reasoning techniques and
disseminate the context-related information to the general
decision making element. Finally, the executive element can
be a system component (e.g., infusion pumps in closed-loop
systems) or the user (e.g., anesthesiologist in open-loop
systems). An example of a DDS is the Smart Anesthesia
Manager that implements a comprehensive set of decision
conditional logic [15]. Moreover, the incorporation of smart
alarm monitoring has been reported as part of a Hybrid
Sedation System [16]. It rapidly integrates multiple signal
sources and models in order to process the information
received (i.e., the reactions to medications), finally gener-
ating a knowledge-driven decision based on similar reason-
ing to experienced anesthesiologists. In cases of emergency,
the DDS are accompanied by alarms for low heart rate (HR),
low respiratory rate (RR), low mean arterial pressure (MAP),
and low peripheral oxygen saturation (SpO2). A new decision
support algorithm based on predictive state representation of
anesthesia has been clinically tested, employing apprentice-
ship learning [17].
In both current clinical practice (open-loop) or automatic
systems (closed-loop), the objective is the same: to achieve
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the best possible outcome for the patient. In order to do
this, it is necessary to reach and maintain the ideal clinical
and therapeutic drug effect as accurately as possible for the
desired time. The clinical common cycle is a quintessential
example of feedback control, and therefore the combination
of clinical and control engineering knowledge has been inten-
sively researched to improve the drug-delivery processes.
The motivation of using automation in clinical anesthesia
delivery is founded in patient safety, a key issue with impli-
cations from multiple matters:
• drug dosing regimen optimization – allows better per-
sonalized approach and knowledge-based precision ther-
apy with higher reproductibility [9], [18];
• outperfomance of manual control – is assured through
better stability of set points, demonstrating consistent
application of best clinical practices [6], [19], [20];
• minimization of accidental over- or under-dosing – is
obtained by avoidance of human distractions or bias
introduced by possible burnout or emotional well-being
of the practitioners [21];
• detection of critical events about patient’s safety –
promptly alerts clinicians for their intervention [16];
• decision support – provides anesthesiologists with the
optimal drug infusion recommendation calculated from
context-aware strategies;
• workload reduction and vigilance increase of clinicians
– benefits from the release of the anesthesiologists from
repetitive trivial tasks, allowing them to focus on deci-
sions that require human cognitive processes, emergency
clinical decisions or medical staff cooperation;
• cost-effectiveness – quantifies the performance of
closed-loop standardized drug delivery in health orga-
nizations, described by the limitation of unnecessary
treatments, cost-savings associated with goal-directed
drug delivery; finally, this technology equals an expert
provider and makes it an opportunity in underdeveloped
regions with minimal resources.
III. CONTROL ENGINEERING ASPECTS FOR ANESTHESIA
APPLICATION
A. INTEGRATED CLOSED-LOOP SYSTEM DESCRIPTION
A descriptive schematic of a closed-loop system is pre-
sented in Fig. 2, distributing anesthesia paradigm in
computer-controlled and common manual optimization,
as follows: multi-input multi-output integrated regulation
(left side) and multiple drug dosing infusions while patient’s
response is monitored (right side). The anesthesiologist has
also impact on the automatic system of drug delivery, being
an active part in the loop by directly operating on the patient
when needed.
A benchmark patient simulator has been developed by the
DYSC research group from Ghent University. This simula-
tor provides the reader with an overview of the embedded
features and possible changes into the state of the patient
as to closely mimic the clinical and physiological states.
The research team has used the 15 years experience in the
topic and literature reports to distill and provide in an under-
standable and accessible manner the complex interactions
and dynamics taking place. Where available, clinical data
has been curated and used in the simulator parameters. The
two systems described are the depth of anesthesia regula-
tion system and the hemodynamic stabilization system. The
objective, by developing such a benchmark simulator, is to
encourage the community to work in a systematic and fair-
to-compare context towards developing computer based con-
trol of multi-drug regulatory problems in this application
field. The novelty is the provision of the patient simulator
as to date no such tools have been previously reported in
literature. The originality of the approach is the inclusion of
synergy effects, antagonist effects, patient variability, clini-
cal value intervals, nociceptor stimulation disturbance, and
co-simulation of anesthestic and hemodynamic states along
with their complex interactions.
The parallelism between the manual clinical practice and
the automatic control optimization can be integrated for
aiming optimal drug delivery by accounting the following
components:
• patient: the system with various complex dynamics;
• surgeon’s actions, often similar per surgery type in terms
of procedural practice, which can be modeled in the
entire process (i.e., surgical stimulation profile added as
disturbance on the system, i.e. patient);
• anesthesiologist’s actions: the disturbances on the
patient in the control loop;
• syringe pumps: the actuators for the controller’s outputs,
for every drug infused in the patient;
• collection of sensors, which deliver information upon
the physiological dynamics of the patient body;
• prediction models: essential for computationally mod-
elling of drug dynamics in the body and the
concentration-effect relationship in each patient;
• multiple-input multiple-output (MIMO) strategy, that
assumes all the usual drugs used in clinical practice
for anesthesia-hemodynamic system and their effects
on each individualized output lest connections can be
missed;
• controller and optimizer: calculate and adapt the optimal
drug dose for the current patient’s state.
B. SPECIFIC ISSUES FROM CONTROL VIEWPOINT
Closed-loop control of anesthesia delivery can be defined
as setpoint following, whereby the controller adapts the sys-
tem’s single or multiple inputs (manipulated variables) based
on the feedback from single or multiple system’s outputs
(controlled variable). As in typical control systems, in anes-
thesia are also envisagedminimal overshoot (as each drug has
a maximum effective dosage with clinical effect), rapid tar-
get reaching, long time target maintaining, stability through
disturbances rejection (surgical stimulation), and robustness
against uncertainties (intra- and inter-patient variability) and
state constraints. Moreover, technical constraints represented
by the time taken for calculation should be overseen for
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FIGURE 2. Closed-loop scheme for complete anesthesia paradigm automation in clinical practice.
anesthesia applied control where models adaptation and con-
trol optimization need to be done online in order to assure a
real-time and minimum delay of drug infusion.
A control engineering viewpoint of the delivery anes-
thetics, in common with all other control problems, will
include consideration of issues such as dynamic modelling,
predictive and adaptive strategies, optimization algorithms,
development of innovative monitors, coping with contextual
uncertainty, and dealing with safety constraints. Since patient
well-being is certainly of paramount concern, all the pre-
sented issues are equally relevant for engineers when design-
ing the control scheme.
1) DYNAMIC MODELLING
The challenge for advancing closed-loop controlled devices
relies on having sufficient understanding of patient pharma-
cological changes and copy them in model-based control
strategies. An important issue is the credibility evidence sup-
porting these models, so Parvinian et al. [22] examine the
various uses of computational patient models in the design
and evaluation of anesthetic delivery systems. The conclusion
is that high variability characterizes the current evidence
types that are already limited in scope and presentation.
The biggest uncertainty required to deal with is patient
modelling, as physiological pharmacokinetics (PK) and phar-
macodynamics (PD) of drug need to be accurately described
through mathematics. Parameter uncertainty due to influ-
ence of surgical stimulation and other interventions or
dynamics that remain un-modeled create hazards in control
design. Present studies are performed in order to develop
PK-PD models for anesthetics, including synergies between
drugs and parameters identification, that can predict the
patients’ response [23], [24]. The introduction of covari-
ates, available for a broad population, drives to uncertainty
reduction.
Commonly, PK-PD compartmental models are used to
predict the drug effect in time, combined with the nonlinear
Hill curve relationship to the measured effect of drug [22].
Variations of the classical models have been studied for
obtaining the most suitable model for control that still main-
tains the physiological accuracy. For example, an extension to
fractional differential equations to account for tissue trapping
has been proposed [25], considering that biological systems
exhibit fractal kinetics (e.g., anomalous diffusion), while dis-
missing the assumption of PK models’ homogeneity. During
the last decade, the meaningful role of fractional calculus in
modelling biological phenomena has emerged toward phar-
macokinetics [26], [27].
Moreover, high fidelity PK-PD models are represented as
transfer functions (input-output relationships) augmented by
a delayed first order system model and the sigmoid linked
to the measured effect (output) [28]. Another example is the
work of Beck [29] that outlines the MIMO piecewise-linear
and linear parameter varying PD models using BIS, testing
them in a feedback control (gain-scheduling and adaptive
methods). Based on another electroencephalographic (EEG)
measure, named the Patient State Index, anesthetics were
recently described on both population and individual lev-
els [30].While PDmodels have been developed for hypnotics
to EEG-based signals and even synergistic drug interactions
have been included, Hill curves that relate the concentration
of opioids to their specific measured effect miss from clinical
validation.
An alternative to classical PK-PD models are fuzzy mod-
els, that have the capacity to neglect some knowledge of
the underlying physiology [31]. Using human heuristic logic,
models that relate directly the infusion rate and BIS, avoid-
ing the complexity of PK, have been proposed by Mar-
tin et al. [32]. Another advantage considered for fuzzymodels
over compartmental ones is the provision of an accurate
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model based on universal approximator property, that can
be used in predictive controllers to compute the optimal
infusion [33]. In fluid therapy for maintaining the safety
in hemodynamics variables, predictive models are used to
accurately predict the response of a given patient to specific
drugs [34].
The challenge for control standpoint represented by the
nonlinearity of the Hill curve has been dealt with through a
computationally efficient Hill curve adaptation strategy for
BIS [35]. Furthermore, this new model formulation reduces
significantly the numerical complexity of the online identifi-
cation task in the process of model’s adaptation. To overcome
the drawback from the high number of PK-PDmodel parame-
ters, but keeping the accuracy adequate for control, the parsi-
moniously parameterizedmodel was the solution [36]. It does
not have a PK-PD model, but it maintains a Wiener structure
(third order state-space system) and a static nonlinearity. Pole
placement choice on model identification has been simulated
for control of opioids in order to achieve a good tracking
performance compared with TCI [37].
Model adaptation or cost-function optimization are the
key factors in dealing with inter- and intra-patient variabil-
ity. Also, the individualized patient models permit the opti-
mal delivery of drug dosing regimens once implemented
in the controller design. This allows moving from conven-
tional generic patient models for drug infusion regulatory
loops to personalized medicine. Several strategies have been
employed for adaptation of the dynamic part of the patient
model, namely the PD parameters that need adaptation in
function of patient’s sensitivity to the drug [38]. The exam-
ples of PD parameters identification techniques include par-
ticle swarm optimization [39], extended Kalman filter [40],
Bayes [41], nonlinear least squares [42], sequential quadratic
programming [32], and genetic algorithm [33], [43]. The
algorithms start from standard models and the values are
continuously adjusted to reflect the time-variant patient’s own
parameters based on the individualized monitored response.
2) SENSORS FOR FEEDBACK
Closed loop control depends upon having a signal on which
to provide feedback of the current state based on mea-
sured outputs. Such that, the anesthetic depth is monitored
with multiple devices that complement the clinical exam-
inations and conventional monitoring of vital signs. The
concept of data acquisition is the fundamental capability
of context-aware systems, characterized also by modelling,
reasoning and dissemination of the decision in order to pro-
vide pervasive assistance to users (in open-loop systems)
and machines (in closed-loop systems). Context-aware sys-
tems are already involved in many healthcare applications,
especially in closed-loop control systems. Sensing context
information is crucial in anesthesia regulation, consider-
ing context defined as the changing execution environment,
where patient’s states are of interest.
Each feedback depends upon unique concerns, such
as the availability of measurements and the natural time
constants associated with the variables of interest (e.g., delay
in monitoring variables, time of patient’s response to drugs
etc.). The nature of the feedback problem varies from NMB
to hypnosis or analgesia. Because of the well defined bio-
markers, the effects of muscle relaxants on depth of NMB
model are assessed by applying a train-of-four (TOF) stimu-
lus of the adductor pollicis muscle, registered by electromyo-
graphy (EMG) or other tools described in [36].
The hypnotic-related changes caused by different drug
concentrations are tracked by EEG-based indices. For the
monitoring of the brain’s electrical activity, several pro-
cessed EEG monitors have been developed, as follows:
Bispectral Index (BIS), State and Response Entropy, Nar-
cotrend Index, Patient State Index (PSI), SNAP II, Cere-
bral State Index, A-Line auditory evoked potential index,
Wavelet-based Anesthetic Value for Central Nervous System
index (WAVCNS ) [44]. The commonly used monitor uses
BIS technology, the first clinically proven and commercially
available direct measure of intraoperative hypnotic state. It is
widely used as feedback in closed-loop control systems for
regulating propofol or dual propofol-remifentanil, but other
indexes have also been implied in automation (e.g.,WAVCNS ).
Based on the assumption that brain reactions to a strong
nociceptive stimulus are not enough masked by anesthetic
drug, BIS has been also used as the monitored variable for
the synergistic drugs effect. However, one cannot consider
EEG-based indexes for indicating the level of analgesia in the
absence of a continuous nociception stimulus [45].
Development of novel sensors to provide a reliable and
objective value of the nociception/ anti-nociception balance
has been impacted closed-loop delivery of proper dosing.
A comprehensive review on the commercial solutions that
have appeared in recent years is done by Ledowski [46].
It tackles the monitoring limitations (e.g., non-specific mark-
ers, unknown robustness against the influence of other
medications, influence of cofounding effects) of each
device, deciding that the evidence to use one nocicep-
tion monitor versus another is overall inconclusive. The
same closure is defined in the recent systematic review of
Meijer et al. [47] on 12 randomized controlled trials that
used nociception devices for analgesia-guidance (i.e., Sur-
gical Pletismographic Index, Analgesia Nociception Index,
Nociception Level Index, Pupillary Pain Index (PPI), CAR-
diovascular DEpth of ANalgesia index). It concluded that
no definitive agreement could be outlined about the effect
of nociceptive monitoring on intraoperative opioid consump-
tion, the results depending on each monitor. Another liter-
ature review by Gruenewald and Dempfle [48] regarding
7 randomized trials using different methods for analgesia
monitoring and opioid peri-operative guidance reported a
non-significant trend towards reduction of administered opi-
oids and emergence time, mostly caused by the high hetero-
geneity of the trials included and by the non-focused clinical
endpoints. Specifically, Nociception Level Index and Pupil-
lometry had been observed in clinical trials to modify anes-
thesia care, resulting in less opioid use for nociception-guided
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anesthesia using the nociception level monitor than the stan-
dard critical care [49], [50].
A systematic analysis is opportune for evidence of anal-
gesia monitors’ usability in computer drug delivery systems.
Additionally, there are various research tools for the measure-
ment of pain and nociception related to pathophysiological
systems [51]. So, it is very important to consider the hypothe-
ses being tested in the selection of the methodology for pain
detection, in order to obtain the data of interest. Different
variables and biomarkers can be considered for monitoring
purposes or for the intended use in closed-loop control as
feedback. Recently, a prototype device has been developed
for intended use in closed-loop control of analgesia deliv-
ery, but only validation in post-anesthesia patients has been
performed until now [52]. ANSPEC-PRO monitor, noninva-
sively measuring pain via skin impedance, allows identifying
amathematicalmodel of the signaling pathways of nociceptor
excitation [53].
In terms of control, there are still challenges around sensors
for hypnosis and analgesia in TIVA, when they need to esti-
mate online the fast changing environment and subsequently
detect the clinically relevant differences (that sometimes may
need good precision). Moreover, when one sensor is used
as feedback in a closed-loop system that regulates only a
specific input, but at the same time, the measured effect may
be influenced by other inputs of the system, the effect of
other drugs on the monitored variable are prior observed
in open-loop set-up [54]. On the other hand, sensors are
validated in typical surgeries that involve specific practices,
different from the common routine (e.g., vascular surgeries,
interventions in children), in order to test the ability of the
device to adequately guide intraoperative drug administra-
tion during such uncertainties [55], [56]. A priori procedu-
ral methods or comparative studies are performed to better
understand anesthesia end-points and to test the performance
of anesthesia monitors under the same conditions [57]–[59].
C. AI: THE SOLUTION IN ANESTHESIA
In recent years, tools from artificial intelligence (AI) have
been approached towards anesthesia monitoring. Large pub-
licly available heterogeneous expert labeled data sets have
provided several benefits for developing clinical decision
tools using deep learning algorithms. One such applica-
tion is EEG-based sleep scoring systems where the deep
learning algorithm is trained to automatically score 5 sleep
stages [60], [61]. Motivated by numerous studies demon-
strating sleep-like inhibition of anesthetic drugs, and major
breakthroughs in the application of deep learning algorithms
for hypnosis monitoring and sleep staging using EEG, a novel
data-repurposing framework to predict anesthesia-induced
hypnotic levels from sleep EEG has been proposed. Deep
learning algorithms learn patterns directly from the raw EEG
data, eliminating the necessity to extract hand-crafted engi-
neering features from EEG for prediction.
The use of deep learning tools to predict anesthetic
drug-induced hypnotic levels based on sleep EEG data can be
useful in developing hypnosis monitoring systems.Moreover,
it has been indicated that deep learning techniques for hyp-
notic state demonstrated feasibility to validate and verify the
robustness of clinical hypothesis using large-scale EEG data
instead of visual assessments using traditional EEG spec-
trogram. It has been also shown that deep learning models
generally allows reliablemonitoring of hypnosis levels in new
patients whose data were not included in the training process,
thus the system can be used ‘‘out of the box’’ [62].
IV. CLOSED-LOOP CONTROL OF ANESTHESIA
Research into closed-loop anesthesia infusion systems has
been increasing over the past decades, with a significant
expansion during the last five years. This section overviews
the control strategies tested in simulation or validated in clin-
ical trials for anesthesia regulation in closed-loop. Database
(ISI Web of Science) searches for ‘‘closed-loop control of
anesthesia’’ yielded 428 articles. Refining the results for
the time period 2015–2020, a number of 176 articles have
been analyzed by years, authors, topic etc. The results are
visually shown in Fig. 3. It can be noticed that the interest
of both researchers and clinicians has increased with years.
Also, it can be seen that Ghent University is the second
top-leading institution with the authors of this article in top
10 leading authors with outstanding results in closed-loop
control of anesthesia. In addition, the authors have also devel-
oped the first complete anesthesia-hemodynamic benchmark
patients simulator. The aim is to encourage the community to
work on in a systematic and fair-to-compare context towards
developing computer based control of multi-drug regulatory
problems.
Although the subtle advantages of closed-loop delivery to
maintain a target BIS value may not be evident to practicing
anesthesiologists, decreasing the percentage of time with BIS
> 60 might help to reduce the risk of awareness. Moreover,
reducing the workload of anesthesiologists with an automated
system can have clinical significance by leaving anesthe-
siologists more time to control emergency hemodynamics,
to manage the airway and ventilation, and to be even more
attentive to the surgical procedure and the assessment of
blood loss, etc. The remaining of this section focuses on the
developed control strategies for general anesthesia with their
advantages and limitations.
A recent review of an overall literature on physio-
logical closed-loop control systems, including anesthesia,
can be found in [31]. The considered control approaches
in anesthesia are summarized as follows: proportional-
integral-derivative control (PID), model predictive control
(MPC), adaptive control (through online estimation and
update of parameters integrated in models or control laws,
or gain scheduling techniques), fuzzy-logic control and
merged schemes, fractional order control (FO), internal
model control (IMC), Bayesian control, back-stepping con-
trol, and positive control [44]. Furthermore, a narrative review
is provided in [9], classifying the anesthesia autonomous
systems in pharmacological (individualized drug titration),
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FIGURE 3. Web of Science records for ‘‘closed loop control of anesthesia’’ between 2014–2020.
mechanical (motorized tasks reproduction), and cognitive
(decision support) robots. Because propofol is the most con-
trolled drug employed in hypnosis regulation, the review
in [63] compares different aspects of control algorithms using
propofol infusion. Additionally, the outcomes of 36 and
12 randomized controlled trials comparing closed-loop
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delivery systems versus manual control proved better perfor-
mance for automation (i.e., better target following, decrease
of over- and under-shooting, reduction of drug consumption
during induction, and reduction of recovery time) [6], [19].
While anesthesia management assumes the integration of
hemodynamics as a component of the complex peri-operative
system, computer-controlled goal-directed hemodynamic
therapy has found increasing interest [64]. In [65] the fea-
sibility of centralized model predictive control (MPC) to the
regulatory problem of hypnosis-hemodynamic variables has
been investigated. This is novel in the application field and
uses linear models which allow later on adaptive tuning to
the patient characteristics, such as drug resistance, sensitivity,
adverse effects, and drug retention times. The particular prob-
lem of drug trapping and non-homogeneous clearance rates
has been addressed in [25].
The only closed-loop system that considers all the three
components of anesthesia for regulation in aMIMO system is
McSleepy (McGill University, Montreal, Canada) [66]. The
completely automated closed-loop system using self-adaptive
PID control has been successfully tested in cardiac surgeries.
However, the infusion for maintaining NMB can be manually
overridden, as the anesthesiologist is notified to confirm the
bolus [67]. An important feature is the ability of the anesthesi-
ologist to inform the device about different stages of surgery,
in order to help its adaptation of drug infusion doses. The sys-
tem incorporates safety features adapted for cardiac surgery
requirements. Also a hybrid sedation system is introduced
in [68] for closed-loop system for propofol sedation (single
input) accompanied by a decision support system to detect
respiratory and hemodynamic critical events (multiple out-
puts), validated in patients undergoing trans-catheter aortic
valve replacement interventions [69]. Another safety system
for closed-loop anesthesia supervision is proposed during
propofol control conditioned by the monitoredWAVCNS [70].
The constrained PID based on viability kernel was imple-
mented in iControl platform for clinical evaluation of con-
trol schemes. The extended safety system guarantees desired
safety constraints, being validated also for reducing conser-
vatism using model falsification [70]. Additionally, the work
in [71] modified the control architecture with an explicit
reference governor scheme for providing safety constraints
satisfaction.
Analgoscore (or the modified version of it, namely
NociMap), included in McSleepy, is the only monitored vari-
able for analgesia reported in the latest clinical trials. Such
that, [72] and [73] combine Analgoscore with PSI or BIS
for feedback regarding the depth of hypnosis and analgesia
in a fuzzy logic controller. Both controllers demonstrated
their feasibility in clinical performance (i.e., maintenance of
an adequate state of anesthetic depth up to almost 3 times
compared to the TCI systems).
Attempting to control the entire anesthesia paradigm,
a multiple single-input single-output (SISO) closed loop
systems for each anesthesia component is used in [74],
such as: dual PIDs for hypnosis and analgesia (through
Infusion Toolbox 95), rule based adaptive PID for fluid
therapy [34], [75], while ventilation is automated by the
comercial device Zeus Infinity C700 Anesthesia (Drager
Medical GmbH, Germany). However, their work does not
integrate all anesthesia components into a single control strat-
egy in order to assume the interactions between the inputs
(i.e. drugs) and the outputs (i.e. monitored variables) of the
system (i.e. the patient), even if no negative interactions
between the 2 controllers have been observed. Studied in
a randomized-controlled trial, the closed-loop system was
superior to manual control and could influence postoperative
outcomes. These systems use the MISO dual PID controller
designed by [76] for maintaining the targeted BIS of propofol
and remifentanil. Randomized clinical trials reported perfor-
mance of the dual controller over manual control in terms of
setpoint maintenance and postoperative outcomes [77], [78].
Several SISO and multiple-input single-output (MISO)
systems for hypnosis control have been developed based
on the common used BIS monitored variable as feedback.
The control from [79] employs genetic algorithms for the
offline tunning of event-based PID or model-based PID [80].
The work is continued in [81] through implementation of
event-based predictive control extended with virtual actuator
deadband. The latest demonstrated similar control accu-
racy with less control system effort compared to classi-
cal time-based predictive controllers. All the controllers are
validated in simulation tests on patient models parameters
extracted from clinical practice, plus generated by Monte
Carlo method. For the control of both propofol and remifen-
tanil co-administration as a MISO problem, [82] proposes a
gain scheduled PID and particle swarm-based optimization
technique. The same MISO design is validated in [41] for
a Bayesian model-based adaptive control strategy using the
software RUGLOOP II (Demed, Belgium). Additionally,
the Bayesian model-based adaptive control is compared to
manually adapted TCI and extended predicition self-adaptive
control (EPSAC) during ICU sedation. Both computer-based
control systems proved overall tighter control than human
infusion, after robustness analysis using prediction error and
spectographic analysis. Another MISO system linked to BIS
for hypnosis and analgesia is the system designed in [83] that
deals with online adaptation based on patients state observa-
tion [84] and positive control law.
The extensive research on the hypnosis regulation based on
propofol to BIS relationship continues in the recent literature,
confirming the need of improving performance even for this
broadly proposed SISO system. The CONCERT-CL (Ver-
yark Technology Co., China) closed-loop infusion system can
automatically maintain the BIS value in an adequate range
better than open-loop systems [85]. The system has been
used for management of BIS by automated propofol infusion
during a clinical trial aiming testing PPI for anti-nociception
evaluation [86]. The work in [20] demonstrates the consistent
performance of the common PID control in a multi-center
trial using the patented CLADS (patent: 502/DEL/2003),
compared with conventional manual control. The same
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system is evaluated under the addition of dexmedetomidine
that complements depth of anesthesia and reduces propo-
fol usage without effecting awakening from anesthesia [87].
Besides, a conventional PID control is modified into an
input-output inversion-based PI control in order to assure
better robustness over inter- and intra-patient variability and
noise [88]. Multiple other SISO adaptive control strategies
for hypnosis include fractional order control [89], [90], ant
colony optimization [39], multi-critic based neuro-fuzzy con-
trol [91], self-organizing fuzzy logic [92], [93], rule-based
fuzzy logic [94], fuzzy predictive control based on genetic
algorithm adaptive model [33], Smith predictor-based con-
trol scheme [95], feedback law with probabilistic certifi-
cation (randomized optimization) [96], (offset-free) hybrid
and model-based multi-parametric MPCs and state estima-
tors [97]–[99].
The monitored variable WAVCNS is used as target in the
works of [100]–[102] for SISO control of hypnosis. Using
multi-model based set of mixed controllers H2/H∞, in [100]
it is achieved robustness to patient’s drug response variabil-
ity, output disturbance, and sensor noise, while attaining a
good set point maintenance. In order to decrease the time of
induction of anesthesia while maintaining robustness, [101]
implements a manually tuned PID and a high-order Q-design
controllers. Moreover, allometric scaling of PK-PD models
reduces interpatient variability, allowing clinical evaluation
of the robust PID control of anesthesia in children. On the
other hand, habituating control is implied in [45] and [103]
for aMISO system, usingWAVCNS for feedback in the control
of hypnosis and analgesia.
The actions of the anesthesiologist are introduced in the
robustness analysis in [14], where the bolus given by the
expert is dealt with as disturbance. MPC-EPSAC strategy
obtained robustness over inter-patient variability and 10 addi-
tional bolus injections in simulation [5], but also IMC has
been reported with similar performance [14].
Going to multiple drugs regulated through BIS in MISO
systems, a PI Smith predictor-based on a delay-free and
delay-included model of the patient outperforms satisfacto-
rily manual practice, while dealing with the BIS delay [104].
On the other hand, increasing complexity of the con-
trol system by adding specific measured output for each
input in MIMO designs provides specific feedback of the
patient’s response to each drug. Such a system is ana-
lyzed in [105] in ICU patients, using BIS and EMG for
hypnosis-analgesia non-overshooting control with integrator,
based on closed-loop eigenvectors and extended Kalman fil-
ter. In [106] a physiologically-basedMPC is simulated, while
making feasible the online clinical implementation due to
the short time required for the controller calculations. Rather
than BIS, cardiac output and respiratory rate are used as
feedback for a two-mode semi-adaptive switching control
of inter-medication synergy between propofol and remifen-
tanil [107]. This work has been extended for infusion of med-
ications with transport delay for the application of regulating
cardiac output with propofol [107]. Moreover, regulation of
propofol infusion is proposed in [108] with a reinforcement
learning-based control scheme using BIS and MAP as con-
trolled variables for ICU sedation during general anesthesia.
The third component of anesthesia, NMB, is reported to
be controlled in SISO closed-loops in [36] and [40], that
compare optimal control problem solved based on Linear
Quadrtic Regulator versus Semi-Definite Program, but also
formulate adaptive controller using positive law. The con-
troller involves the inverseWiener model’s static nonlinearity
and a positive compartmental control law for the linearized
system, while reducing the complexity. It has been validated
in trials using Galeno supervisory automatic drug adminis-
tration system. Furthermore, adaptive PID with time-varying
gain based on parsimonious Wiener PK-PD model is pro-
posed in [109], avoiding oscillations.
In Table 1, an overview of the latest results in closed-loop
control of anesthesia is presented.
V. DISCUSSION
Control of anesthesia rises several challenges for both clinical
and engineering specialists, that once solvedwould lead to the
following perspectives:
• The engagement of human cognitive process into
the system has a great potential to increase the
intuitive-driven detection of the risky events; there is
the need to develop technology enablers and strategies
for placing the human in the loop (i.e., understand and
model the human-contributed action; adapt the con-
troller with the interaction between anesthesiologist and
CPS entities).
• The offset of non-technological barriers (i.e., recogni-
tion and clinical adoption) constitutes a critical factor in
success of socio-technical systems for medical decision
support, poorly addressed by researchers, but essential.
• The complex procedure of general anesthesia can be
computer-assisted in clinical practice; the high system
complexity needs to be undertaken in terms of suitable
modelling of MIMO interactions and stable control with
feedback from multiple variables; robustness simulation
should deal with the already studied intra-patient and
inter-patient model variability and uncertainty, but also
with the additional bolus in the loop and surgical stimu-
lation (for disturbance rejection).
• The ability of a (model predictive) controller to antici-
pate future system’s output could play an essential role in
emergency; it demands accurate patient’s model, or sta-
bility analysis that studies the unmodeled dynamics;
model uncertainty and lack of persistent excitation in
manipulated inputs to allow model identification are the
two additional challenges from patient view-point. The
uncertainty comes from the inter/intra-patient variability
in response to drug amounts and effects, which requires
either adaptive models or robust control strategies.
• Individualized patient’s dose-response relationship esti-
mation in real time will enable personalized treatment;
adaptation strategy based on online identification of the
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population models parameters is required to support and
enhance the medical stuff operations in changing envi-
ronments; compensation of the PD model nonlinearity
and variable delays poses special challenges for control
design and control stability.
• MIMO strategy is the closest to clinical practice, as mul-
tiple drug doses are optimally infused in the patient
based on specific output measurement; opioid-analgesia
balance requires a direct measure of the specific anal-
gesic effect, so an analysis of the current available com-
mercial nociception devices should be done.
• Teleanesthesia, when anesthesia is remotely controlled,
could become possible whenever personnel with great
qualifications is not available or need support, but also
during robotic surgeries.
• In order to ease the introduction of automatic systems
in routine use, the technology needs to be reliable and
understandable for the medical experts; for the lat-
est, user-friendly interface and transparent theoretical
methodologies need to be provided together with safe
boundaries working mode and smart alarms; on the
other hand, when exploring the risk-benefit relationship,
aspects should be considered in real clinical conditions.
• In order to increase the reliability of practitioners in
automation, tests in clinical trials of the feasibility of the
closed-loop controller are necessary as proof of concept;
later, larger clinical studies are needed in a multi-center
design to provide evidence based on reproductibility
of the results and comparison to a control group (i.e.
manual infusion); this is necessary to overcome the
opinions that the simulations of new controllers meet the
well-known engineering principles for the validation of
the innovative control strategy, but the clinical signifi-
cance lacks to be demonstrated.
• The navigation of the regulatory landscape for medical
devices that incorporate advanced levels of automation
is an important issue that needs to be taken in considera-
tion by the stakeholders, from the viewpoints of design,
implementation, and evaluation considerations.
VI. CONCLUSION
Anesthesia titration in a closed-loop controlled manner
remains a research tool that is not yet implemented in clinical
care. Although the advance in research on both physiology
and technology has enabled automation of the complex anes-
thesia process, the actual control strategies are far from the
mature state needed to be integrated in standard hospital use.
The issue can be explained by the limitation of the current
control systems to not copy the real-life clinical routine of
the complex anesthesia by means of integrated regulation of
all anesthesia-related drugs (for hypnosis, analgesia, neuro-
muscular blockade, hemodynamics, respiratory dynamics).
However, this is just a question of time, as several in-silico
simulations but also clinical trials have demonstrated the
benefits of anesthesia regulation in terms of patient safety,
experts support, and economical impact.
The breakthrough in this area will be the development of
medical cyber physical-human systems that integrate context-
awareness, devices communication, human-machine coop-
eration, control and optimization algorithms for accurately
making the right decision for drugs infusion.
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